Beta-Caryophyllene Enhances the Anti-Tumor Activity of Cisplatin in Lung Cancer Cell Lines through Regulating Cell Cycle and Apoptosis Signaling Molecules.

Ahmed, Emad A; Abu Zahra, Hamad; Ammar, Rebai Ben; Mohamed, Maged Elsayed; Ibrahim, Hairul-Islam M

Ahmed, Emad A; Abu Zahra, Hamad; Ammar, Rebai Ben; Mohamed, Maged Elsayed; Ibrahim, Hairul-Islam M.

Afiliação

Ahmed EA; Biological Sciences Department, College of Science, King Faisal University, Al-Ahsa 31982, Saudi Arabia.
Abu Zahra H; Laboratory of Molecular Physiology, Zoology Department, Faculty of Science, Assiut University, Assiut 71515, Egypt.
Ammar RB; Biological Sciences Department, College of Science, King Faisal University, Al-Ahsa 31982, Saudi Arabia.
Mohamed ME; Biological Sciences Department, College of Science, King Faisal University, Al-Ahsa 31982, Saudi Arabia.
Ibrahim HM; Laboratory of Aromatic and Medicinal Plants, Center of Biotechnology of Borj-Cedria, Technopole of Borj-Cedria PBOX 901, Hammam-Lif 2050, Tunisia.

Molecules ; 27(23)2022 Nov 30.

Article em En | MEDLINE | ID: mdl-36500446

Assuntos

Antineoplásicos; Neoplasias Pulmonares; Humanos; Cisplatino; Simulação de Acoplamento Molecular; Proliferação de Células; Neoplasias Pulmonares/metabolismo; Apoptose; Ciclo Celular; Linhagem Celular; Quinases Ciclina-Dependentes; Linhagem Celular Tumoral; Antineoplásicos/farmacologia; Antineoplásicos/uso terapêutico; Resistencia a Medicamentos Antineoplásicos

Palavras-chave

A549; Beta-Caryophyllene (BCP); cisplatin; lung cancer cell lines; synergistic chemotherapy

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Neoplasias Pulmonares / Antineoplásicos Tipo de estudo: Prognostic_studies Limite: Humans Idioma: En Ano de publicação: 2022 Tipo de documento: Article

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google